| | Variable | NOF () | OF () | | |
| | Age (years) () | | | | 0.774 | | Sex, male/female | 33/46 | 7/8 | | 0.821 | | Time of onset (hours) | | | | 0.705 | | 0-24 h | 28 | 7 | | | | 24-48 h | 27 | 4 | | | | 48-72 h | 24 | 4 | | | | Etiology | | | | 0.417 | | Biliary, (%) | 43 | 11 | | | | Alcohol, (%) | 8 | 2 | | | | Hypertriglyceridemia, (%) | 13 | 1 | | | | Other, (%) | 15 | 1 | | | | APPACHE II score | | | | 0.011 | | RANSON score | | | | <0.001 | | Length of hospital stay (days) | 9 (7, 12) | 16 (15, 36) | -4.06 | <0.001 | | Hospital cost (CNY) | 32435 (22203, 41689) | 75075 (62198, 174771) | | <0.001 | | Inflammatory markers (pg/mL) | Median (P25, P75) | Median (P25, P75) | | | | IL1a | 2.35 (1.55, 4.25) | 1.55 (1.28, 2.56) | -1.76 | 0.474 | | IL1b | 3.32 (1.73, 8.18) | 3.16 (1.69, 11.38) | -0.03 | 0.895 | | IL4 | 2.33 (1.42, 4.75) | 2.08 (1.57, 3.67) | -0.49 | 0.431 | | IL6 | 24.43 (10.18, 42.3) | 106.9 (78.97, 188.13) | -4.82 | <0.001 | | IL8 | 4.52 (2.99, 7.86) | 14.14 (5.68, 18.03) | -3.76 | 0.002 | | IL10 | 1.51 (0.83, 2.62) | 8.25 (4.33, 14.98) | -4.67 | 0.003 | | IL13 | 0.58 (0.32, 0.76) | 0.31 (0.2, 0.65) | -1.36 | 0.348 | | MCP1 | 152.64 (125.18, 192.46) | 234.11 (165.02, 280.94) | -1.01 | 0.001 | | IFNg | 1.56 (0.93, 2.49) | 1.21 (0.78, 2.24) | -2.71 | 0.505 | | TNFa | 5.78 (2.34, 11.16) | 4.4 (2.2, 11.55) | -0.45 | 0.624 | | PCT (ng/mL) | 0.42 (0.12, 1.18) | 2.07 (0.33, 23.38) | -2.65 | <0.001 | | CRP (mg/mL) | 90 (40.1, 90) | 90 (84.9, 90) | -1.02 | 0.84 | | Routine blood test | | | | | | WBC, ×109/L () | | | | 0.244 | | LY, ×109/L median (P25, P75) | 1.13 (0.85, 1.57) | 0.99 (0.85, 1.25) | -1.172 | 0.241 | | MO, ×109/L median (P25, P75) | 0.53 (0.44, 0.78) | 0.45 (0.34, 0.95) | -0.749 | 0.454 | | NE, ×109/L () | | | | 0.161 | | Immunity markers (%) | | | | | | CD3 T lymphocytes | | | | 0.002 | | CD3CD4 T lymphocytes | | | | 0.007 | | CD3CD8 cytotoxic T lymphocytes | 23.06 (17.56, 28.53) | 21.56 (13.21, 26.84) | -1.1 | 0.272 | | CD16+ CD56+ natural killer cells | 10.9 (6.7, 18.39) | 14.67 (7.63, 17.39) | -0.49 | 0.624 | | CD19+ B lymphocytes | 14.5 (10.2, 19.8) | 25.57 (17.9, 29.97) | -3.929 | <0.001 | | CD4CD8 cytotoxic T lymphocytes | 1.76 (1.29, 2.24) | 1.55 (1.09, 2.87) | -0.083 | 0.934 |
|
|
